Vis enkel innførsel

dc.contributor.authorTiam, Appolinaire
dc.contributor.authorGill, Michelle
dc.contributor.authorMachekano, Rhoderick
dc.contributor.authorTukei, Vincent
dc.contributor.authorMokone, Majoalane
dc.contributor.authorViana, Shannon
dc.contributor.authorLetsie, Mosilinyane
dc.contributor.authorTsietso, Mots'Oane
dc.contributor.authorSeipati, Irene
dc.contributor.authorKhachane, Cecilia
dc.contributor.authorNei, Marethabile
dc.contributor.authorMohai, Florence
dc.contributor.authorTylleskär, Thorkild
dc.contributor.authorGuay, Laura
dc.date.accessioned2021-06-29T13:52:06Z
dc.date.available2021-06-29T13:52:06Z
dc.date.created2020-12-14T22:13:32Z
dc.date.issued2020
dc.PublishedPLOS ONE. 2020, 15 (10), .
dc.identifier.issn1932-6203
dc.identifier.urihttps://hdl.handle.net/11250/2762401
dc.description.abstractIntroduction Population-based HIV-free survival at 18–24 months of age among HIV-exposed infants in high prevalence settings in the era of treatment for all is largely unknown. We conducted a community-based survey to determine outcomes of HIV-exposed infants at 18–24 months in Lesotho. Methods Between November 2015 and December 2016, we conducted a survey among households with a child born 18–24 months prior to data collection. Catchment areas from 25 health facilities in Butha-Buthe, Maseru, Mohale’s Hoek and Thaba-Tseka districts were randomly selected using probability proportional to size sampling. Consecutive households were visited and eligible consenting caregivers and children were enrolled. Rapid HIV antibody testing was performed on mothers of unknown HIV status (never tested or tested HIV-negative >3 months prior) and their children, and to children born to known HIV-positive mothers. Information on demographics, health-seeking behavior, HIV, and mortality were captured for mothers and children, including those who died. The difference in survival between subgroups was determined using the log-rank test. Results Of the 1,852 mothers/caregivers enrolled, 570 mothers were HIV-positive. The mother-to-child HIV transmission rate was 5.7% [95% CI: 4.0–8.0]. The mortality rate was 2.6% [95% CI: 1.6–4.2] among HIV-exposed children compared to 1.4% (95% CI: 0.9–2.3) among HIV-unexposed children. HIV-free survival was 91.8% [95% CI: 89.2–93.8] among HIV-exposed infants. Disclosure of mother’s HIV status (aOR = 4.9, 95% CI: 1.3–18.2) and initiation of cotrimoxazole prophylaxis in the child (aOR = 3.9, 95% CI: 1.2–12.6) were independently associated with increased HIV-free survival while child growth problems (aOR = 0.2, 95% CI: 0.09–0.5) were independently associated with reduced HIV-free survival. Conclusion Even in the context of lifelong antiretroviral therapy among pregnant and breastfeeding women, HIV has a significant effect on survival among HIV-exposed children compared to unexposed children. Lesotho has not reached elimination of HIV transmission from mother to child.en_US
dc.language.isoengen_US
dc.publisherPublic Library of Science.en_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.title18-24-month HIV-free survival as measurement of the effectiveness of prevention of mother-to-child transmission in the context of lifelong antiretroviral therapy: Results of a community-based surveyen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2020 Tiam et al.en_US
dc.source.articlenumbere0237409.en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doi10.1371/journal.pone.0237409
dc.identifier.cristin1859775
dc.source.journalPLOS ONEen_US
dc.source.4015
dc.source.1410
dc.identifier.citationPLOS ONE. 2020, 15 (10), e0237409.en_US
dc.source.volume15en_US
dc.source.issue1oen_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal